https://www.selleckchem.com/pr....oducts/azd0156-azd-0
Our findings point to the clinical significance of in-ICU glucose control in severe COVID patients. 180 mg/dl) is more common in non survivors who also showed a significantly higher glucose variability in the first 48 h since ICU admission. Our findings point to the clinical significance of in-ICU glucose control in severe COVID patients. The triglyceride glucose (TyG) index is a marker of insulin resistance. However, the prognostic value thereof in patients with chronic heart failure (CHF) and type 2 diabetes remains unclear.
Like
Comment
Share
